Årsrapport 2012 - PRE Management
Årsrapport 2012 - PRE Management
Årsrapport 2012 - PRE Management
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>PRE</strong><br />
II<br />
12<br />
<strong>Årsrapport</strong> <strong>2012</strong><br />
<strong>PRE</strong> China Private Equity II AS<br />
Organisasjonsnummer 992 201 681
Innhold<br />
Forvalters rapport 4<br />
<strong>PRE</strong> China Private Equity II AS<br />
Årsberetning <strong>2012</strong> 5<br />
Regnskap og balanse 6<br />
Kontantstrømoppstilling 9<br />
Noter 10<br />
Revisjonsberetning <strong>PRE</strong> China Private Equity II AS 14<br />
China New Enterprise Investment Fund II JVC<br />
Revisjonsberetning 18<br />
Regnskap 20<br />
Noter 24<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 3
Forvalters rapport<br />
<strong>PRE</strong> China Private Equity II AS (”<strong>PRE</strong> China II”) gir<br />
norske investorer tilgang til å investere med<br />
internasjonale profesjonelle og institusjonelle<br />
aktører i direkteinvesteringer i Kina.<br />
<strong>PRE</strong> China II har som formål å investere alle sine<br />
midler i fondet China New Enterprise Investment<br />
Fund II CJV (”CNEI II”). <strong>PRE</strong> China II ble gjennom<br />
emisjoner fra februar 2008 til desember 2009 tilført<br />
emisjonsproveny på NOK 380 mill. og har kommitert<br />
USD 62,5 mill. i CNEI II. Totalt har internasjonale<br />
investorer kommitert USD 255 mill. til CNEI II.<br />
<strong>PRE</strong> China II har innbetalt USD 35,3 mill. per<br />
31.12.<strong>2012</strong>. Utestående investeringsforpliktelse er<br />
USD 27,1 mill.<br />
Denne årsrapporten er delt i tre. Først kommer<br />
forvalters rapport for året, deretter presenteres<br />
det norske selskapets regnskap, og til slutt<br />
presenteres det kinesiskbaserte ’limited partnership’<br />
som gjennomfører investeringene og oppfølgingen<br />
av disse.<br />
CNEI II består av 24 ’limited partners’. <strong>PRE</strong> China<br />
II er én av disse. De øvrige deltagerne er fra Japan,<br />
Kina, Midtøsten, Storbritannia, Luxemburg,<br />
Liechtenstein, Sveits og Tyskland. Investorene er<br />
familier, investeringsselskaper, offentlige<br />
investeringsselskaper, banker og pensjonsfond.<br />
Forvalters rapport<br />
Kinesiske styresmakters pågående arbeid for en<br />
kontrollert økonomisk vekstnedgang pågikk for<br />
fullt gjennom <strong>2012</strong>. Kinesisk bruttonasjonalprodukt<br />
(“BNP”) endte opp 7,8 % sammenlignet med 2011,<br />
marginalt over økonomiske prognoser på 7,7 %.<br />
Hovedårsaken til den overordnede vekstnedgangen<br />
var et fall i statlige investeringer samt lavere etterspørsel<br />
etter kinesiske varer og tjenester fra USA<br />
og et Europa med vedvarende gjeldsproblematikk.<br />
Innenlandsk forbrukerkonsum sto som den største<br />
bidragsyteren til videre vekst med 51,8 % av den<br />
totale BNP-oppgangen.<br />
4 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
Pål Raaum<br />
Styreformann<br />
<strong>PRE</strong> <strong>Management</strong><br />
Dette til tross for at 4. kvartal markerte den tredje<br />
sammenhengende måneden med fall i innenlandsk<br />
forbruk.<br />
Videre ble det knyttet stor spenning til det kinesiske<br />
lederskiftet som fant sted i mars 2013 og hvilken<br />
effekt dette ville ha på det kinesiske, og den globale,<br />
økonomien. Slik forventet ble det i overgangsperioden<br />
gjennom andre halvår <strong>2012</strong> og årsskiftet<br />
<strong>2012</strong>-2013 igangsatt få statlige tiltak fra den<br />
sittende regjeringen med en nevneverdig effekt på<br />
den kinesiske økonomien.<br />
Majoriteten av økonomiske eksperter og personer<br />
som følger utviklingen i den kinesiske økonomien<br />
på en daglig basis, heriblant Johannes Schoeter og<br />
forvaltningsteamet bak CNEI II, mener den kinesiske<br />
økonomien har gått over i en stabil og positiv fase.<br />
Forvalter ser dog ingen sterke indikasjoner på en<br />
kraftig økning i vekst i 2013. Økonomisk vekst vil<br />
på mellomlang og lang sikt avhenge av økonomiske<br />
reformer; lik behandling av private bedrifter,<br />
reduksjon i statlige monopoler, liberalisering og<br />
reformer av det kinesiske finansielle systemet, kamp<br />
mot korrupsjon, samt betydelig mindre innblanding<br />
fra statlig byråkrati.<br />
Verdijustert egenkapital (”VEK”) per 31.12.12 for<br />
<strong>PRE</strong> China II er beregnet til NOK 7,96 pr. aksje,<br />
fremdeles under aksjonærenes innskutte kapital på<br />
om lag NOK 10,00 pr. aksje. CNEI IIs eldre porteføljeselskaper<br />
har sett en god dollar-denominert verdiutvikling<br />
gjennom andre halvår <strong>2012</strong>. Fondet er dog<br />
fremdeles i en investeringsfase, og nye porteføljeinvesteringer<br />
vil slå negativt ut på VEK. Dette fordi<br />
kapital overført fra <strong>PRE</strong> China II til CNEI II skal dekke<br />
både porteføljeinvesteringer og tilknyttede kostnader<br />
(blant annet finansiell og juridisk due diligence).<br />
Ledig investeringskapital som bokføres ut av<br />
balansen til <strong>PRE</strong> China II vil således ikke veies opp<br />
likt-for-likt av vekst i porteføljeverdier.<br />
I tillegg har et svekket vekslingsforhold mellom<br />
USD og NOK påvirket VEK negativt gjennom <strong>2012</strong>.<br />
Per 31.12.12 var denne vekslingskursen USD/NOK<br />
5,5664, mot USD/NOK 5,9927 per 31.12.11.
Årsberetning for <strong>2012</strong><br />
<strong>PRE</strong> CHINA PRIVATE EQUITY II AS<br />
Virksomheten til <strong>PRE</strong> China Private Equity II AS (“Selskapet”) er å investere direkte eller indirekte i fondet<br />
China New Enterprise Investment Fund II CJV (“CNEI II”).<br />
Selskapets forretningsadresse er i Oslo.<br />
Selskapet ble etablert 2. januar 2008. Selskapet har per balansedagen ikke generert inntekter fra sine<br />
investeringer som følge av at CNEI II fortsatt er i en investeringsfase. Ingen investeringer er realisert.<br />
Selskapets resultat i <strong>2012</strong> ble et tap på NOK 17,6 mill.<br />
Selskapets totalkapital er NOK 295,1 mill. per balansedagen og egenkapitalen utgjør NOK 295,1 mill.<br />
Likviditetsbeholdningen er på NOK 126,6 mill. og anses som tilfredsstillende.<br />
Selskapet har per 31. desember <strong>2012</strong> innbetalt omlag USD 35,3 mill. i CNEI II.<br />
Selskapet har ingen ansatte og styret består av 3 menn. Det er ikke iverksatt spesielle tiltak som har<br />
betydning for likestilling eller arbeidsmiljøet.<br />
Selskapets bransje og virksomhet medfører verken forurensing eller utslipp som kan være til skade for det ytre<br />
miljø. I samsvar med regnskapslovens § 3-3 bekreftes det at forutsetningen om fortsatt drift er lagt til grunn<br />
ved utarbeidelse av regnskapet.<br />
Etter styrets oppfatning gir det fremlagte resultatregnskapet og balanse, med tilhørende noter fyldestgjørende<br />
informasjon om driften av Selskapet ved årsskiftet.<br />
Pål Raaum<br />
Sign.<br />
Styrets leder<br />
Per Morten Bjørseth<br />
Sign.<br />
Styremedlem<br />
Oslo, den 21. juni 2013<br />
Johannes Schoeter<br />
Sign.<br />
Styremedlem<br />
Tobias Junge<br />
Sign.<br />
Daglig leder<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 5
Resultatregnskap<br />
<strong>PRE</strong> CHINA PRIVATE EQUITY II AS<br />
DRIFTSKOSTNADER Note <strong>2012</strong> 2011<br />
Andre driftskostnader 1, 8 3 475 564 3 571 900<br />
SUM DRIFTSKOSTNADER 3 475 564 3 571 900<br />
DRIFTSRESULTAT -3 475 564 -3 571 900<br />
FINANSINNTEKTER OG -KOSTNADER<br />
Renteinntekter 589 933 504 108<br />
Annen finansinntekt 7 0 3 569 783<br />
Nedskrivning av finansielle anleggsmidler 6 0 29 104 488<br />
Rentekostnader 387 198<br />
Annen finanskostnad 7 14 768 687 0<br />
RESULTAT AV FINANSPOSTER -14 179 141 -25 030 795<br />
ORDINÆRT RESULTAT FØR SKATT -17 654 706 -28 602 696<br />
Skatter på ordinært resultat 3 0 0<br />
ÅRSRESULTAT -17 654 706 -28 602 696<br />
OVERFØRINGER<br />
Overført fra overkursfond -17 654 706 -28 602 696<br />
SUM OVERFØRINGER 4 -17 654 706 -28 602 696<br />
6 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS
Balanse<br />
<strong>PRE</strong> CHINA PRIVATE EQUITY II AS<br />
EIENDELER Note <strong>2012</strong> 2011<br />
ANLEGGSMIDLER<br />
FINANSIELLE ANLEGGSMIDLER<br />
Investering i aksjer og andeler 6 168 331 014 97 737 762<br />
SUM FINANSIELLE ANLEGGSMIDLER 168 331 014 97 737 762<br />
SUM ANLEGGSMIDLER 168 331 014 97 737 762<br />
OMLØPSMIDLER<br />
FORDRINGER<br />
Andre kortsiktige fordringer 131 188 672 830<br />
SUM FORDRINGER 131 188 672 830<br />
Bankinnskudd, kontanter o.l. 2 126 640 180 214 376 696<br />
SUM OMLØPSMIDLER 126 771 367 215 049 526<br />
SUM EIENDELER 295 102 381 312 787 289<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 7
Balanse<br />
<strong>PRE</strong> CHINA PRIVATE EQUITY II AS<br />
EGENKAPITAL OG GJELD Note <strong>2012</strong> 2011<br />
EGENKAPITAL<br />
INNSKUTT EGENKAPITAL<br />
Aksjekapital 3 620 312 3 620 312<br />
Overkursfond 291 440 750 309 095 456<br />
SUM INNSKUTT EGENKAPITAL 4, 5 295 061 062 312 715 768<br />
SUM EGENKAPITAL 295 061 062 312 715 768<br />
GJELD<br />
KORTSIKTIG GJELD<br />
Leverandørgjeld 26 006 42 920<br />
Annen kortsiktig gjeld 15 313 28 601<br />
SUM KORTSIKTIG GJELD 41 319 71 521<br />
SUM GJELD 41 319 71 521<br />
SUM EGENKAPITAL OG GJELD 295 102 381 312 787 289<br />
Pål Raaum<br />
Sign.<br />
Styrets leder<br />
8 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
Per Morten Bjørseth<br />
Sign.<br />
Styremedlem<br />
Oslo, den 21. juni 2013<br />
Johannes Schoeter<br />
Sign.<br />
Styremedlem<br />
Tobias Junge<br />
Sign.<br />
Daglig leder
Kontantstrømoppstilling<br />
<strong>PRE</strong> CHINA PRIVATE EQUITY II AS<br />
KONTANTSTRØMMER FRA OPERASJONELLE AKTIVITETER<br />
<strong>2012</strong> 2011<br />
Kontantstrømmer fra operasjonelle aktiviteter<br />
Resultat før skattekostnad -17 654 706 -256 210<br />
Endring i leverandørgjeld -16 914 -1 958<br />
Endring i andre tidsavgrensningsposter 528 354 113 772<br />
Netto kontantstrømmer fra operasjonelle aktiviteter A -17 143 266 -144 396<br />
KONTANTSTRØMMER FRA INVESTERINGSAKTIVITETER<br />
Investeringer i aksjer og andeler -70 593 252 -44 631 191<br />
Netto kontantstrømmer fra investeringsaktiviteter B -70 593 252 -44 631 191<br />
KONTANTSTRØMMER FRA FINANSIERINGSAKTIVITETER<br />
Endring i egenkapital 0 0<br />
Netto kontantstrømmer fra finansieringsaktiviteter C 0 0<br />
Netto endring i kontanter og kontantekvivalenter A+B+C -87 736 518 -44 775 587<br />
Beholdning av kontanter og kontantekv. ved periodens begynnelse 214 376 696 259 152 283<br />
Beholdning av kontanter og kontantekv. ved periodens slutt 126 640 180 214 376 696<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 9
Noter til regnskapet <strong>2012</strong><br />
<strong>PRE</strong> CHINA PRIVATE EQUITY II AS<br />
Årsregnskapet er satt opp i samsvar med regnskapsloven og NRS 8 - God regnskapsskikk for små foretak.<br />
Hovedregel for vurdering og klassifisering av eiendeler og gjeld<br />
Eiendeler bestemt til varig eie eller bruk er klassifisert som anleggsmidler. Andre eiendeler er klassifisert<br />
omløpsmidler. Fordringer som skal tilbakebetales innen ett år er uansett klassifisert som omløpsmidler.<br />
Ved klassifisering av kortsiktig og langsiktig gjeld er tilsvarende kriterier lagt til grunn.<br />
Anleggsmidler vurderes til anskaffelseskost, men nedskrives til virkelig verdi når verdifallet ikke forventes å<br />
være forbigående. Anleggsmidler med begrenset økonomisk levetid avskrives planmessig. Langsiktig gjeld<br />
balanseføres til nominelt mottatt beløp på etableringstidspunktet. Langsiktig gjeld oppskrives ikke til virkelig<br />
verdi som følge av renteendring.<br />
Omløpsmidler vurderes til laveste av anskaffelseskost og virkelig verdi. Kortsiktig gjeld balanseføres til<br />
nominelt mottatt beløp på etableringstidspunktet. Kortsiktig gjeld oppskrives ikke til virkelig verdi som følge<br />
av renteendring.<br />
Enkelte poster er vurdert etter andre regler, og redegjøres for nedenfor.<br />
Fordringer<br />
Kundefordringer og andre fordringer oppføres til pålydende.<br />
Skatter<br />
Skattekostnaden i resultatregnskapet omfatter både periodens betalbare skatt og endring i utsatt skatt. Utsatt<br />
skatt er beregnet med 28 % på grunnlag av de midlertidige forskjeller som eksisterer mellom regnskapsmessige<br />
og skattemessige verdier, samt ligningsmessig underskudd til fremføring ved utgangen av regnskapsåret.<br />
Skatteøkende og skattereduserende midlertidige forskjeller som reverseres eller kan reversere i samme<br />
periode er utlignet og nettoført. Utsatt skattefordel på netto skattereduserende forskjeller er ikke utlignet<br />
og på underskudd til fremføring, balanseføres i den grad skattefordelen antas å kunne utnyttes gjennom<br />
fremtidige skattepliktige overskudd.<br />
Inntekter<br />
Selskapets inntekter knytter seg til avkastning på investeringen i aksjer og renteinntekter på bankinnskudd.<br />
Mottatt utbytte fra investeringen inntektsføres i samme periode som utbetaling skjer, dersom utbyttet<br />
representerer opptjent inntekt. Renteinntekter inntektsføres etter hvert som de påløper.<br />
Investering i aksjer<br />
Investering i aksjer vurderes til anskaffelseskost, men nedskrives til virkelig verdi når verdifallet<br />
ikke forventes å være forbigående.<br />
Valuta<br />
Pengeposter i utenlandsk valuta som er omløpsmidler omregnes til valutakurs på balansedagen.<br />
10 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS
Note 1 Lønnskostnader, antall ansatte, godtgjørelser, lån til ansatte, m.v<br />
Selskapet har ingen ansatte og det er ikke utbetalt godtgjørelse til styret. Selskapet er ikke pliktig til å ha<br />
ordning for obligatorisk tjenestepensjon i hht. lov om dette.<br />
Revisor<br />
Kostnadsført revisjonshonorar for <strong>2012</strong> utgjør NOK 26 875 (inkl. mva.), herav NOK 6 625 for andre tjenester.<br />
Note 2 Bankinnskudd, kontanter o.l.<br />
Total likviditetsbeholdning per 31.12.<strong>2012</strong>: 126 640 180<br />
Herav bundne bankinnskudd: 0<br />
Selskapet har ingen forpliktelser som skal dekkes av bundne bankinnskudd per 31.12.<strong>2012</strong>.<br />
Note 3 Skatt<br />
Årets skattekostnad fremkommer slik: <strong>2012</strong> 2011<br />
Betalbar skatt på årets resultat 0 0<br />
Brutto endring utsatt skatt 0 0<br />
Skattekostnad ordinært resultat 0 0<br />
Betalbar skatt i årets skattekostnad fremkommer slik:<br />
Ordinært resultat før skattekostnad -17 654 706 -28 602 696<br />
Permanente forskjeller -9 575 112 18 737 891<br />
Endring midlertidige forskjeller 0 0<br />
Benyttet fremførbart underskudd 0 0<br />
Grunnlag betalbar skatt -27 229 818 -9 864 805<br />
Skatt, 28 % 0 0<br />
Betalbar skatt på årets resultat 0 0<br />
Betalbar skatt i balansen fremkommer slik:<br />
Betalbar skatt på årets resultat 0 0<br />
Sum betalbar skatt 0 0<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 11
Spesifikasjon av grunnlag for utsatt skatt:<br />
Forskjeller som utlignes:<br />
12 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
Endring <strong>2012</strong> 2011<br />
Aksjer og andre verdipapirer 0 -29 104 488 29 104 488<br />
Fremførbart underskudd 27 229 817 -102 769 396 -75 539 579<br />
Sum 27 229 817 -131 873 884 -104 644 067<br />
Utsatt skatt/skattefordel 7 624 349 -36 924 688 -29 300 339<br />
Selskapet har valgt å ikke bokføre utsatt skattefordel.<br />
Note 4 Egenkapital<br />
Aksjekapital Overkursfond Sum<br />
Egenkapital 01.01.<strong>2012</strong> 3 620 312 309 095 456 312 715 768<br />
Årsresultat 0 -17 654 706 -17 654 706<br />
Egenkapital 31.12.<strong>2012</strong> 3 620 312 291 440 750 295 061 062<br />
Note 5 Aksjekapital og aksjonærinformasjon<br />
Aksjekapitalen i selskapet per 31.12.<strong>2012</strong> består av følgende aksjeklasser:<br />
Antall Pålydende Balanseført<br />
Ordinære aksjer 36 203 124 0,10 3 620 312<br />
Eierstruktur:<br />
De 10 største aksjonærene per 31.12.<strong>2012</strong> var:<br />
Stemme-/<br />
Ord. aksjer eierandel<br />
RISHAUG FINANS AS 337 425 0,9 %<br />
MOLVER AS 319 300 0,9 %<br />
KNUT ÅM 319 300 0,9 %<br />
CORUNA INVEST AS 313 654 0,9 %<br />
SKIPS AS PEGASUS 309 430 0,9 %<br />
ROMARIO INVEST AS 305 966 0,8 %<br />
ASHEIM INVESTMENTS AS 300 942 0,8 %<br />
KANUTO HOLDING AS 271 875 0,8 %<br />
HAUKEN INVEST AS 248 231 0,7 %<br />
TANERA A/S 239 161 0,7 %<br />
Totalt antall aksjer 2 965 284 8,2 %
Note 6 Investeringer<br />
Selskap EK Resultat Bokført verdi Kostpris<br />
CNEI Fund II L.P 257 205 949 -18 231 118 168 331 014 197 435 502<br />
Lokasjon: Cayman Island<br />
Eierandel: 62,19 %<br />
Note 7 Finansposter<br />
Annen finansinntekt-/kostnad består i sin helhet av valutagevinst-/tap tilknyttet utestående fordringer, gjeld<br />
og bankinnskudd i USD.<br />
Note 8 Annen driftskostnad<br />
Poster under annen driftskostnad i årsregnskapet fordeler seg slik:<br />
<strong>2012</strong> 2011<br />
Revisjonshonorar 26 875 20 000<br />
Juridisk bistand 50 313 56 632<br />
Forretningsførerhonorar 405 112 399 967<br />
Honorar til VPS 30 945 36 548<br />
Forvaltningshonorar inkl. mva. 2 797 128 2 752 170<br />
Trykksaker og kopiering 103 565 202 346<br />
Annen kostnad 61 627 104 238<br />
Sum annen driftskostnad 3 475 564 3 571 900<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 13
14 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 15
16 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
CHINA NEW ENTERPRISE<br />
INVESTMENT FUND II (PARALLEL), L.P.<br />
Independent Auditor's Report and<br />
Consolidated Financial Statements<br />
For the year ended 31 December <strong>2012</strong>
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
INDEPENDENT AUDITOR'S REPORT AND CONSOLIDATED FINANCIAL STATEMENTS<br />
FOR THE YEAR ENDED 31 DECEMBER <strong>2012</strong><br />
CONTENTS PAGE(S)<br />
INDEPENDENT AUDITOR'S REPORT 1 - 2<br />
CONSOLIDATED STATEMENT OF COM<strong>PRE</strong>HENSIVE INCOME 3<br />
CONSOLIDATED STATEMENT OF FINANCIAL POSITION 4<br />
CONSOLIDATED STATEMENT OF CHANGES IN PARTNERS' CAPITAL 5<br />
CONSOLIDATED STATEMENT OF CASH FLOWS 6<br />
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 7 - 24<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 17
18 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 19
20 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
CONSOLIDATED STATEMENT OF FINANCIAL POSITION<br />
AT 31 DECEMBER <strong>2012</strong><br />
(Expressed in US$)<br />
NOTES <strong>2012</strong> 2011<br />
US$ US$<br />
Assets<br />
Cash and bank balances 2,293,084 1,253,752<br />
Prepayment and other receivables 8 3,192 245,495<br />
Financial assets at fair value through profit and loss 6 44,003,308 _________ 28,166,701 _________<br />
Total assets 46,299,584 29,665,948<br />
_________ _________<br />
Liabilities<br />
Other payables 47,958 339,769<br />
Accrued expenses 44,751 19,500<br />
_________ _________<br />
Total liabilities 92,709 359,269<br />
_________ _________<br />
Net assets 46,206,875 29,306,679<br />
_________ _________<br />
_________ _________<br />
Partners' capital<br />
General partner 45,977 -<br />
Limited partners 46,160,898 29,306,679<br />
_________ _________<br />
Total partners' capital 46,206,875 29,306,679<br />
_________ _________<br />
_________ _________<br />
The notes on pages 7 to 24 form part of these consolidated financial statements.<br />
- 4 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 21
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
CONSOLIDATED STATEMENT OF CHANGES IN PARTNERS' CAPITAL<br />
FOR THE YEAR ENDED 31 DECEMBER <strong>2012</strong><br />
(Expressed in US$)<br />
22 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
<strong>2012</strong> 2011<br />
Partners' capital as at 1 January 29,306,679 19,790,552<br />
Capital contribution during the year 20,175,404 12,318,034<br />
Net decrease in partners' capital resulting from operation (3,275,208) (2,801,907)<br />
_________ _________<br />
Partners' capital as at 31 December 46,206,875 29,306,679<br />
_________ _________<br />
_________ _________<br />
The notes on pages 7 to 24 form part of these consolidated financial statements.<br />
- 5 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
CONSOLIDATED STATEMENT OF CASH FLOWS<br />
FOR THE YEAR ENDED 31 DECEMBER <strong>2012</strong><br />
(Expressed in US$)<br />
<strong>2012</strong> 2011<br />
Cash flow from operating activities<br />
Net decrease in partners' capital from operations __________ (3,275,208) __________ (2,801,907)<br />
Adjustments for:<br />
Net unrealised losses on financial assets at<br />
fair value through profit or loss 508,784 20,317<br />
Decrease/(increase) in other receivable and prepayment 242,302 (243,616)<br />
Increase in other payables and accrued expenses 2,947 24,581<br />
Foreign exchange translation gain (10,248) (8,120)<br />
__________ __________<br />
Net cash outflow from operating activities (2,531,423) (3,008,745)<br />
__________ __________<br />
Cash flow from investing activities<br />
Purchase of investment (16,614,897) (12,385,862)<br />
__________ __________<br />
Net cash used in from investing activities (16,614,897) (12,385,862)<br />
__________ __________<br />
Cash flow from financing activities<br />
Contributions paid by the partners 20,175,404 12,318,034<br />
__________ __________<br />
Net cash generated from financing activities 20,175,404 12,318,034<br />
__________ __________<br />
Effective of exchange rate changes on cash and cash equivalents 10,248 8,120<br />
__________ __________<br />
Net change in cash and cash equivalents 1,039,332 (3,068,453)<br />
__________ __________<br />
Cash and cash equivalents at the beginning of the period 1,253,752 4,322,205<br />
__________ __________<br />
Cash and cash equivalents at the end of the period,<br />
represented by cash and bank balances<br />
__________<br />
2,293,084<br />
__________ __________<br />
1,253,752<br />
__________<br />
The notes on pages 7 to 24 form part of these consolidated financial statements.<br />
- 6 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 23
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br />
FOR THE YEAR ENDED 31 DECEMBER <strong>2012</strong><br />
(Expressed in US$)<br />
1. GENERAL INFORMATION<br />
China New Enterprise Investment Fund II (Parallel), L.P. (the "Fund") is a private equity fund<br />
incepted in Cayman Islands under the Exempted Limited Partnership Laws (2007 Revision) of the<br />
Cayman Islands, as amended from time to time. The Fund obtained its business license on 10<br />
June 2008 (date of inception). The Fund was set up as a parallel fund of China New Enterprise<br />
Investment Fund II, L.P. ("Primary Fund"), a Cayman Islands exempted limited partnership. The<br />
terms of the Funds all continue until the Primary Fund is dissolved from final admission date in<br />
accordance with the contract of the Fund (the "Fund Contract").<br />
The general partner and the investment manager of the Fund are China New Enterprise Investment<br />
Fund II GP Ltd. (the "General Partner") and New Enterprise <strong>Management</strong> Co. Ltd. (the<br />
"Investment Manager") respectively. The partners committed total capital of US$100,500,000 of<br />
which US$56,838,376 representing 56.56% of the total commitment has been accumulatively<br />
contributed as at 31 December <strong>2012</strong>.<br />
As at 31 December <strong>2012</strong>, the Fund has one directly wholly-owned subsidiary, Nordic Invest Co.<br />
Limited ("Nordic"), which was incorporated in Hong Kong.<br />
On September 24, 2008, China New Enterprise Investment Fund II ("CNEI Fund II CJV") was<br />
incorporated in the P.R. China ("PRC") as sino-foreign co-operative joint venture. The Fund,<br />
China New Enterprise Investment Fund II, L.P. and two PRC investors jointly control the CNEI<br />
Fund II CJV. For the period of 2011, The Fund committed a total capital of US$21,462,500 to<br />
CNEI Fund II CJV, which accounts for 38.31% of CNEI Fund II CJV's total committed capital of<br />
US$56,030,000. For the period of <strong>2012</strong>, CNEI Fund II CJV increased its total commitment to<br />
US$81,030,000, and the Fund's committed capital to CNEI Fund II CJV has increased to<br />
US$31,393,325, which accounts for 38.74% of CNEI Fund II CJV's total committed capital of<br />
US$81,030,000. As at 31 December <strong>2012</strong>, CNEI Fund II CJV has been accumulatively<br />
contributed US$ 26,040,907 by the Fund, which represents 82.95% of the total commitment.<br />
The Fund, its direct subsidiary and joint venture are hereinafter collectively referred to as the<br />
"Fund". All of the subsidiaries and joint venture are generally used as special purpose vehicles to<br />
purchase shares in other private companies on behalf of the Fund.<br />
The Fund's objective is to make equity, quasi-equity, debt and quasi-debt investments side by side<br />
with the Primary Fund, in companies with substantial operations in, or which plan to have<br />
substantial operations in, Greater China (comprising mainland China, Hong Kong, Macau and<br />
Taiwan) and Singapore.<br />
24 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
- 7 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
2. APPLICATION OF NEW AND REVISED INTERNATIONAL FINANCIAL REPORTING<br />
STANDARDS ("IFRS")<br />
In the current year, the Fund has applied the following new and revised IFRSs.<br />
Amendments to IFRS 7 Disclosures - Transfers of Financial Assets<br />
The Fund has applied for the first time the amendments to IFRS 7 Disclosures - Transfers of<br />
Financial Assets in the current year. The amendments increase the disclosure requirements for<br />
transactions involving the transfer of financial assets in order to provide greater transparency<br />
around risk exposures when financial assets are transferred. The application of the amendments<br />
has no material effect on the Fund's operating results, financial position or other comprehensive<br />
income in the current year.<br />
New and revised IFRSs issued but not yet effective<br />
IFRS 9 Financial Instruments 3<br />
IFRS 10 Consolidated Financial Statements 1<br />
IFRS 11 Joint Arrangements 1<br />
IFRS 12 Disclosure of Interests in Other Entities 1<br />
IFRS 13 Fair Value Measurement 1<br />
Amendments to IFRS 7 Disclosures - Offsetting Financial Assets and Financial Liabilities 1<br />
Amendments to IFRS 7 Mandatory Effective Date of IFRS 9 and Transition<br />
and IFRS 9 Disclosures 2<br />
Amendments to IFRS 10, Consolidated Financial Statements, Joint Arrangements<br />
IFRS 11 and IFRS 12 and Disclosure of Interests in Other Entities: Transition Guidance 1<br />
Amendments to IFRS 10,<br />
IFRS 12 and IAS* 27 Investment Entities 2<br />
IAS 27 (Revised 2011) Separate Financial Statements 1<br />
IAS 28 (Revised 2011) Investments in Associates and Joint Ventures 1<br />
Amendments to IAS 1 Presentation of Items of Other Comprehensive Income 4<br />
Amendments to IAS 32 Offsetting Financial Assets and Financial Liabilities 2<br />
1<br />
2<br />
3<br />
4<br />
Effective for annual periods beginning on or after 1 January 2013.<br />
Effective for annual periods beginning on or after 1 January 2014.<br />
Effective for annual periods beginning on or after 1 January 2015.<br />
Effective for annual periods beginning on or after 1 July <strong>2012</strong>.<br />
* IAS - International Accounting Standard<br />
- 8 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 25
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
2. APPLICATION OF NEW AND REVISED INTERNATIONAL FINANCIAL REPORTING<br />
STANDARDS ("IFRS") - continued<br />
26 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
New and revised IFRSs issued but not yet effective - continued<br />
IFRS 9 Financial Instruments<br />
IFRS 9 issued in 2009 introduces new requirements for the classification and measurement of<br />
financial assets. IFRS 9 amended in 2011 includes the requirements for the classification and<br />
measurement of financial liabilities and for derecognition.<br />
Key requirements of IFRS 9 are described as follows:<br />
IFRS 9 requires all recognized financial assets that are within the scope of IAS 39<br />
Financial Instruments: Recognition and Measurement to be subsequently measured at<br />
amortized cost or fair value. Specifically, debt investments that are held within a business<br />
model whose objective is to collect the contractual cash flows, and that have contractual<br />
cash flows that are solely payments of principal and interest on the principal outstanding<br />
are generally measured at amortized cost at the end of subsequent accounting periods. All<br />
other debt investments and equity investments are measured at their fair values at the end<br />
of subsequent reporting periods. In addition, under IFRS 9, entities may make an<br />
irrevocable election to present subsequent changes in the fair value of an equity investment<br />
(that is not held for trading) in other comprehensive income, with only dividend income<br />
generally recognized in profit or loss.<br />
With regard to the measurement of financial liabilities designated as at fair value through<br />
profit or loss, IFRS 9 requires that the amount of changes in the fair value of the financial<br />
liability that is attributable to changes in the credit risk of that liability is presented in other<br />
comprehensive income, unless the recognition of the effects of changes in the liability's<br />
credit risk in other comprehensive income would create or enlarge an accounting mismatch<br />
in profit or loss. Changes in fair value of financial liabilities attributable to changes in the<br />
financial liability's credit risk are not subsequently reclassified to profit or loss.<br />
Previously, under IAS 39, the entire amount of the change in the fair value of the financial<br />
liability designated as fair value through profit or loss was presented in profit or loss.<br />
IFRS 9 is effective for annual periods beginning on or after 1 January 2015, with earlier<br />
application permitted.<br />
The Fund is considering the impact of IFRS 9 on the consolidated financial statements and the<br />
timing of its application.<br />
New and revised Standards on consolidation, joint arrangements, associates and disclosures<br />
In June 2011, a package of five standards on consolidation, joint arrangements, associates and<br />
disclosures was issued, including IFRS 10, IFRS 11, IFRS 12, IAS 27 (as revised in 2011) and<br />
IAS 28 (as revised in 2011).<br />
Key requirements of these five standards are described below.<br />
- 9 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
2. APPLICATION OF NEW AND REVISED INTERNATIONAL FINANCIAL REPORTING<br />
STANDARDS ("IFRS") - continued<br />
New and revised IFRSs issued but not yet effective - continued<br />
New and revised Standards on consolidation, joint arrangements, associates and disclosures -<br />
continued<br />
IFRS 10 replaces the parts of IAS 27 Consolidated and Separate Financial Statements that deal<br />
with consolidated financial statements and SIC-Interpretation 12 Consolidation - Special Purpose<br />
Entities will be withdrawn upon the effective date of IFRS 10. Under IFRS 10, there is only one<br />
basis for consolidation, that is, control. In addition, IFRS 10 includes a new definition of control<br />
that contains three elements: (a) power over an investee, (b) exposure, or rights, to variable returns<br />
from its involvement with the investee, and (c) the ability to use its power over the investee to<br />
affect the amount of the investor's returns. Extensive guidance has been added in IFRS 10 to deal<br />
with complex scenarios.<br />
IFRS 11 replaces IAS 31 Interests in Joint Ventures. IFRS 11 deals with how a joint arrangement<br />
of which two or more parties have joint control should be classified. SIC-Interpretation 13 Jointly<br />
Controlled Entities - Non-Monetary Contributions by Venturers will be withdrawn upon the<br />
effective date of IFRS 11. Under IFRS 11, joint arrangements are classified as joint operations or<br />
joint ventures, depending on the rights and obligations of the parties to the arrangements. In<br />
contrast, under IAS 31, there are three types of joint arrangements: jointly controlled entities,<br />
jointly controlled assets and jointly controlled operations. In addition, joint ventures under IFRS<br />
11 are required to be accounted for using the equity method of accounting, whereas jointly<br />
controlled entities under IAS 31 can be accounted for using the equity method of accounting or<br />
proportionate accounting.<br />
IFRS 12 is a disclosure standard and is applicable to entities that have interests in subsidiaries,<br />
joint arrangements, associates and/or unconsolidated structured entities. In general, the disclosure<br />
requirements in IFRS 12 are more extensive than those in the current standards.<br />
In June <strong>2012</strong>, the amendments to IFRS 10, IFRS 11 and IFRS 12 were issued to clarify certain<br />
transitional guidance on the application of these IFRSs for the first time.<br />
These five standards, together with amendments relating to the transitional guidance, are effective<br />
for annual periods beginning on or after 1 January 2013 with earlier application permitted<br />
provided that all of these standards are applied at the same time.<br />
The General Investor anticipates that the application of the above new and revised standards and<br />
amendments issued but not yet effective is not expected to have a material effect on the Fund's<br />
operating results, financial position or other comprehensive income.<br />
- 10 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 27
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
2. APPLICATION OF NEW AND REVISED INTERNATIONAL FINANCIAL REPORTING<br />
STANDARDS ("IFRS") - continued<br />
New and revised IFRSs issued but not yet effective - continued<br />
IFRS 13 Fair Value Measurement<br />
IFRS 13 establishes a single source of guidance for fair value measurements and disclosures about<br />
fair value measurements. The Standard defines fair value, establishes a framework for measuring<br />
fair value, and requires disclosures about fair value measurements. The scope of IFRS 13 is<br />
broad; it applies to both financial instrument items and non-financial instrument items for which<br />
other IFRSs require or permit fair value measurements and disclosures about fair value<br />
measurements, except in specified circumstances. In general, the disclosure requirements in IFRS<br />
13 are more extensive than those in the current standards. For example, quantitative and<br />
qualitative disclosures based on the three-level fair value hierarchy currently required for financial<br />
instruments only under IFRS 7 Financial Instruments: Disclosures will be extended by IFRS 13 to<br />
cover all assets and liabilities within its scope.<br />
IFRS 13 is effective for annual periods beginning on or after 1 January 2013, with earlier<br />
application permitted. The General Partner anticipates that the application of the new standard is<br />
not expected to have a material effect on the Fund's consolidated financial statements and<br />
disclosures in the consolidated financial statements.<br />
Amendments to IAS 32 Offsetting Financial Assets and Financial Liabilities and amendments to<br />
IFRS 7 Disclosures - Offsetting Financial Assets and Financial Liabilities<br />
The amendments to IAS 32 clarify existing application issues relating to the offsetting<br />
requirements. Specifically, the amendments clarify the meaning of "currently has a legally<br />
enforceable right of set-off" and "simultaneous realization and settlement".<br />
The amendments to IFRS 7 require entities to disclose information about rights of offset and<br />
related arrangements (such as collateral posting requirements) for financial instruments under an<br />
enforceable master netting agreement or similar arrangement.<br />
The amended offsetting disclosures are required for annual periods beginning on or after 1 January<br />
2013 and interim periods within those annual periods. The disclosures should also be provided<br />
retrospectively for all comparative periods. However, the amendments to IAS 32 are not effective<br />
until annual periods beginning on or after 1 January 2014, with retrospective application required.<br />
The General Partner anticipates that the application of these amendments to IAS 32 and IFRS 7 is<br />
not expected to have a material effect on the Fund's disclosures being made with regard to<br />
offsetting financial assets and financial liabilities.<br />
28 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
- 11 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
2. APPLICATION OF NEW AND REVISED INTERNATIONAL FINANCIAL REPORTING<br />
STANDARDS ("IFRS") - continued<br />
New and revised IFRSs issued but not yet effective - continued<br />
Amendments to IFRS 10, IFRS 12 and IAS 27 Investment Entities<br />
The amendments to IFRS 10 introduce an exception to consolidating subsidiaries for an<br />
investment entity, except where the subsidiaries provide services that relate to the investment<br />
entity's investment activities. Under the amendments to IFRS 10, an investment entity is required<br />
to measure its interests in subsidiaries at fair value through profit or loss.<br />
To qualify as an investment entity, certain criteria have to be met. Specifically, an entity is<br />
required to:<br />
obtain funds from one or more investors for the purpose of providing them with<br />
professional investment management services;<br />
commit to its investor(s) that its business purpose is to invest funds solely for returns from<br />
capital appreciation, investment income, or both; and<br />
measure and evaluate performance of substantially all of its investments on a fair value<br />
basis.<br />
Consequential amendments to IFRS 12 and IAS 27 have been made to introduce new disclosure<br />
requirements for investment entities.<br />
The amendments to IFRS 10, IFRS 12 and IAS 27 are effective for annual periods beginning on or<br />
after 1 January 2014, with early application permitted. The General Partner anticipates that the<br />
application of the amendments will have effect on the Fund as the Fund is an investment entity.<br />
Amendments to IAS 1 Presentation of Items of Other Comprehensive Income<br />
The amendments to IAS 1 Presentation of Items of Other Comprehensive Income introduce new<br />
terminology for the statement of comprehensive income and income statement. Under the<br />
amendments to IAS 1, a 'statement of comprehensive income' is renamed as a 'statement of profit<br />
or loss and other comprehensive income' and an 'income statement' is renamed as a 'statement of<br />
profit or loss'. The amendments to IAS 1 retain the option to present profit or loss and other<br />
comprehensive income in either a single statement or in two separate but consecutive statements.<br />
However, the amendments to IAS 1 require items of other comprehensive income to be presented<br />
into two categories: (a) items that will not be reclassified subsequently to profit or loss; and (b)<br />
items that may be reclassified subsequently to profit or loss when specific conditions are met.<br />
Income tax on items of other comprehensive income is required to be allocated on the same basis -<br />
the amendments do not change the option to present items of other comprehensive income either<br />
before tax or net of tax.<br />
The amendments to IAS 1 are effective for annual periods beginning on or after 1 July <strong>2012</strong>. The<br />
presentation of items of other comprehensive income will be modified accordingly when the<br />
amendments are applied in the future accounting periods.<br />
- 12 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 29
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
3. SIGNIFICANT ACCOUNTING POLICIES<br />
Statement of compliance<br />
The consolidated financial statements have been prepared in accordance with IFRS.<br />
Basis of preparation<br />
The consolidated financial statements have been prepared on the historical cost basis, except for<br />
certain financial assets and liabilities which are measured at fair value. Historical cost is generally<br />
based on the fair value of the consideration given in exchange for assets.<br />
As the Fund is a parallel fund of the Primary Fund, the General Partner's interest and capital is not<br />
included in the Fund's consolidated financial statement, but included in the Primary Fund's<br />
consolidated financial statement.<br />
The principal accounting policies adopted are as follows:<br />
Basis of consolidation<br />
The consolidated financial statements incorporate the consolidated financial statements of the<br />
Fund and entities (including special purpose entities) controlled by the Fund (its subsidiaries).<br />
Control is achieved where the Fund has the power to govern the financial and operating policies of<br />
an entity so as to obtain benefits from its activities.<br />
Subsidiaries are consolidated from the date on which control is transferred to the Fund and are no<br />
longer consolidated from the date that control ceases. Transactions and balances among the Fund<br />
and its subsidiaries are eliminated upon consolidation.<br />
The existence and effect of potential voting rights that are presently exercisable or presently<br />
convertible are considered when assessing whether the Fund controls another entity. Where<br />
necessary, adjustments are made to the financial statements of subsidiaries to bring their<br />
accounting policies into line with those used by other members of the Fund.<br />
All inter-company transactions and balances have been eliminated in full on consolidation.<br />
A joint venture is a contractual arrangement whereby the Fund and other parties undertake an<br />
economic activity that is subject to joint control (i.e. when the strategic financial and operating<br />
policy decisions relating to the activities of the joint venture require the unanimous consent of the<br />
parties sharing control).<br />
Joint venture arrangements that involve the establishment of a separate entity in which each<br />
venture has an interest are referred to as jointly controlled entities.<br />
The Fund reports its interests in jointly controlled entity using proportionate consolidation, except<br />
when the investment is classified as held for sale, in which case it is accounted for in accordance<br />
with IFRS 5 Non-current Assets Held for Sale and Discontinued Operations.<br />
The Fund's share of the assets, liabilities, income and expenses of jointly controlled entities is<br />
combined with the equivalent items in the consolidated financial statements on a line-by-line basis.<br />
30 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
- 13 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
3. SIGNIFICANT ACCOUNTING POLICIES - continued<br />
Dividend and interest income<br />
Dividend income from investments is recognized when the shareholder's right to receive payment<br />
has been established (provided that it is probable that the economic benefits will flow to the Fund<br />
and the amount of income can be measured reliably).<br />
Interest income from a financial asset is recognized when it is probable that the economic benefits<br />
will flow to the Fund and the amount of income can be measured reliably. Interest income is<br />
accrued on a time basis, by reference to the principal outstanding and at the effective interest rate<br />
applicable, which is the rate that exactly discounts estimated future cash receipts through the<br />
expected life of the financial asset to that asset's net carrying amount on initial recognition.<br />
Foreign currencies<br />
Items included in the consolidated financial statements of the Fund are measured in the currency<br />
of the primary economic environment in which the Fund operates (the "functional currency"). The<br />
consolidated financial statements of the Fund are presented in currency units ("US$"), which is the<br />
Fund's functional and presentation currency. The primary objective of the Fund is to generate<br />
returns in US$, its capital-raising currency. The liquidity of the Fund is managed on a day-to-day<br />
basis in US$ in order to handle the issue, acquisition and resale of the Fund's redeemable shares.<br />
Transaction in currencies other than US$ is translated at the foreign currency exchange rate ruling<br />
at the date of transaction. Monetary assets and liabilities denominated in foreign currencies are<br />
translated to US$ at the foreign currency closing exchange rate ruling at the year end date.<br />
Foreign currency exchange differences arising from translation and unrealised gains and losses on<br />
disposal or settlements of monetary assets and liabilities denominated in foreign currencies that<br />
are measured at fair value are translated to US$ at the foreign currency exchange rates ruling at the<br />
dates that the value were determined. Net foreign exchange gains/(losses) on non-monetary and<br />
monetary financial assets and liabilities other than those classified as at fair value through profit or<br />
loss are included in foreign currency gains/(losses).<br />
For the purpose of presenting the consolidated financial statements, the assets and liabilities of the<br />
Fund's foreign operations are expressed in currency units using exchange rates prevailing at the<br />
end of the reporting period. Income and expense items are translated at the average exchange<br />
rates for the period, unless exchange rates fluctuated significantly during that period, in which<br />
case the exchange rates at the dates of the transactions are used. Exchange differences arising, if<br />
any, are recognised in other comprehensive income and accumulated in partners' capital<br />
(attributed to non-controlling interests as appropriate).<br />
Cash and cash equivalents<br />
Cash comprises current deposits with banks. Cash equivalents are short term, highly liquid<br />
investments that are readily convertible to known amounts of cash and which are subject to<br />
insignificant changes in value, and are held for the purpose of meeting short term cash<br />
commitments rather than for investment or other purpose.<br />
- 14 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 31
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
3. SIGNIFICANT ACCOUNTING POLICIES - continued<br />
Financial instruments<br />
32 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
Financial assets and financial liabilities are recognised on the Fund's consolidated statements of<br />
assets and liabilities when the Fund becomes a party to the contractual provisions of the<br />
instrument. Financial assets and financial liabilities are initially measured at fair value.<br />
Transaction costs that are directly attributable to the acquisition or issue of financial assets and<br />
financial liabilities (other than financial assets and financial liabilities at fair value through profit<br />
or loss) are added to or deducted from the fair value of the financial assets or financial liabilities,<br />
as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of<br />
financial assets or financial liabilities at fair value through profit or loss are recognised<br />
immediately in profit or loss.<br />
Financial assets<br />
The Fund's financial assets are classified as financial assets at fair value through profit or loss and<br />
loans and receivables. All regular way purchases or sales of financial assets are recognised and<br />
derecognised on a trade date basis. Regular way purchases or sales are purchases or sales of<br />
financial assets that require delivery of assets within the frame established by convention in the<br />
marketplace. The accounting policies adopted in respect of each category of financial assets are<br />
set out below.<br />
Financial assets at fair value through profit or loss<br />
Financial assets at fair value through profit or loss has two subcategories, including financial<br />
assets held for trading and those designated at fair value through profit or loss on initial<br />
recognition.<br />
A financial asset other than a financial asset held for trading may be designated as at fair value<br />
through profit or loss upon initial recognition if:<br />
such designation eliminates or significantly reduces a measurement or recognition<br />
inconsistency that would otherwise arise; or<br />
the financial asset forms part of a group of financial assets or financial liabilities or both,<br />
which is managed and its performance is evaluated on a fair value basis, in accordance<br />
with the Fund 's documented risk management or investment strategy, and information<br />
about the grouping is provided internally on that basis;<br />
At each reporting date subsequent to initial recognition, financial assets at fair value through profit<br />
or loss are measured at fair value, with changes in fair value recognised directly in profit or loss in<br />
the period in which they arise.<br />
- 15 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
3. SIGNIFICANT ACCOUNTING POLICIES - continued<br />
Financial instruments - continued<br />
Financial assets at fair value through profit or loss - continued<br />
The fair values of investments in securities designated at fair value through profit or loss are<br />
determined as follows:<br />
The Fund may hold investments in publicly traded securities, some of which are subject to selling<br />
restrictions or held in escrow. Public securities held by the Fund are valued at their closing price<br />
unless there are legal restrictions in trading, in which case the price may be discounted. For<br />
investments that are not currently traded in a public market or are subject to restrictions on resale,<br />
fair values are determined by the General Partner. Factors considered in determining the fair<br />
values of these investments include purchase price, estimates of liquidation value, subsequent<br />
equity financing involving third parties or a significant change in operating performance or<br />
potential resulting in a change in valuation in accordance with the terms of the Fund Contract.<br />
Loans and receivables<br />
Loans and receivables are non-derivative financial assets with fixed or determinable payments that<br />
are not quoted in an active market. At each reporting date subsequent to initial recognition, loans<br />
and receivables (including deposit for investments in securities, other receivables and cash and<br />
cash equivalents) are carried at amortised cost using the effective interest method, less any<br />
identified impairment losses. Interest income is recognised by applying the effective interest rate,<br />
except for short-term receivables when the recognition of interest would be immaterial.<br />
Financial liabilities<br />
Financial liabilities are classified according to the substance of the contractual arrangements<br />
entered into and the definitions of a financial liability.<br />
Financial liabilities, including other payables and advance from limited partners, are subsequently<br />
measured at amortised cost, using the effective interest method.<br />
Derecognition<br />
Financial assets are derecognised when the contractual rights to receives cash flows from the asset<br />
expire; or the financial asset is transferred and the Fund has transferred substantially all the risks<br />
and rewards of ownership of the financial asset. On derecognition of a financial asset, the<br />
difference between the asset's carrying amount and the sum of the consideration received and<br />
receivable is recognised in profit or loss.<br />
Financial liabilities are derecognised when the obligation specified in the relevant contract is<br />
discharged, cancelled or expired. The difference between the carrying amount of the financial<br />
liability derecognised and the consideration paid and payable is recognised in profit or loss.<br />
Allocation of profits and losses<br />
Each item of income, gains, losses or deduction of the Fund will generally be allocated among the<br />
capital accounts of the partners in order to give effect to the provisions of the Fund Contract<br />
relating to distributions and winding up.<br />
- 16 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 33
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
3. SIGNIFICANT ACCOUNTING POLICIES - continued<br />
Income taxes<br />
The Fund is exempted for income tax in the Cayman Islands for a period of fifty years from 24<br />
June 2008. Accordingly, no provision for income taxes has been provided in the accompanying<br />
consolidated financial statements, as the partners are individually responsible for reporting income<br />
or loss based on their respective share of the Fund's income and expenses for income tax purposes.<br />
The Chinese State Administration of Taxation (SAT) released a tax circular (Guoshuihan No. 698<br />
- "Circular 698") on 15 December 2009 that addresses the transfer of shares by foreign nonresident<br />
companies. It specifies the Peoples' Republic of China ("PRC") income tax implications<br />
with respect to foreign companies on gains derived from the sale (directly or indirectly) of equity<br />
shares of a Chinese company. Circular 698, which is effective retrospectively to 1 January 2008,<br />
specifies that foreign non-resident companies which had transferred shares of investments in<br />
China indirectly in the past two years are required to file a series of documents with the Chinese<br />
tax authority. Furthermore, such foreign non-resident companies may be subject to Chinese<br />
income tax based on the anti-avoidance rule. Circular 698 will have a significant impact on<br />
companies that use offshore holding companies as vehicles to invest in China, which will increase<br />
companies' administrative and compliance burdens. Currently, the General Partner is<br />
contemplating on how to handle the compliance requirement and might consider conducting<br />
appropriate filing with the in-charge tax offices. As Circular 698 is relatively new, there is no<br />
additional official administrative rule on how to interpret such transfer by the SAT. Considering<br />
that it's subject to the discretion of the SAT (the competent tax authorities) whether this type of<br />
indirect share transfer shall be levied on PRC income tax, the General Partner believes at their<br />
best estimation that there would be no additional PRC tax on such disposition of equities shares of<br />
its investments except for the withholding taxes it already accrued which has been deducted<br />
against the fair value of its investment. The General Partner would like to closely monitor the<br />
development of this issue in the future, but also like to remind all limited partners that the SAT<br />
(the competent tax authorities) may have different judgment on this issue if further official<br />
interpretation of this Circular becomes available.<br />
Based on the above analysis and the facts and circumstances, including, notably, the uncertainty of<br />
the interpretation and administrative practices associated with the applicable PRC tax law as of 31<br />
December <strong>2012</strong>, the General Partner determined that there is no material impact to the Fund's<br />
consolidated financial statements as of 31 December <strong>2012</strong> and for the year then ended. However,<br />
the General Partner will continue to assess financial statement impact of PRC tax regulations and<br />
new interpretive guidance released by the PRC tax authorities.<br />
Related parties<br />
Parties are considered related if one party has the ability, directly or indirectly, to control the other<br />
party or exercise significant influence over the other party in making financial or operational<br />
decisions.<br />
34 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
- 17 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
4. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION<br />
UNCERTAINTY<br />
In the application of the Fund's accounting policies, which are described in note 3 to the<br />
consolidated financial statements, the General Partner is required to make judgements, estimates<br />
and assumptions about the carrying amounts of assets and liabilities that are not readily apparent<br />
from other sources. The estimates and associated assumptions are based on historical experience<br />
and other factors that are considered to be relevant. Actual results may differ from these<br />
estimates.<br />
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to<br />
accounting estimates are recognised in the period in which the estimate is revised if the revision<br />
affects only that period or in the period of the revision and future periods if the revision affects<br />
both current and future periods.<br />
The following is the critical judgement, apart from those involving estimations (see below), that<br />
the General Partner has made in the process of applying the entity's accounting policies and that<br />
have the most significant effect on the amounts recognised in the consolidated financial<br />
statements.<br />
The fair values of investments totalling US$ 44,003,308 or approximately 95.23% of the partners'<br />
capital as at 31 December <strong>2012</strong> has been determined by the General Partner of the Fund based on<br />
the methodologies described in Note 3 "Financial instruments" and Note 5.2 "Fair value of<br />
financial instruments" in the absence of readily ascertainable market values. Because of the<br />
inherent uncertainty of valuations, estimated fair values of such investments may differ<br />
significantly from the value of the assets and liabilities that not readily apparent from other<br />
sources. Actual results may differ from these estimates.<br />
5. FINANCIAL INSTRUMENTS<br />
5.1 Financial risk management<br />
The Fund is exposed to a variety of financial risks including: market price risk, interest rate risk,<br />
currency risk, credit risk and liquidity risk. The General Partner attributes great importance to<br />
professional risk management, beginning by carefully diversifying the sourcing of access to<br />
premier private equity investment opportunities, and proper understanding and negotiation of<br />
appropriate terms and conditions. The General Partner actively monitors the investments made<br />
through ongoing interviews with Investment Manager, reviewing analyst reports and consolidated<br />
financial statements. The Fund has investment guidelines that set out its overall business<br />
strategies, its tolerance for risk and its general risk management philosophy and has established<br />
processes to monitor and control the economic impact of these risks.<br />
Market price risk<br />
The investments held in the portfolio may be realized only after several years and their fair values<br />
may change significantly. The General Partner provides the Fund with investment<br />
recommendations that are consistent with the Fund's objective. The General Partner's<br />
recommendations are approved by the Investment Committee.<br />
- 18 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 35
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
5. FINANCIAL INSTRUMENTS - continued<br />
5.1 Financial risk management - continued<br />
Market price risk - continued<br />
The Fund's listed investments are subject to market price risk inherent in all its listed securities<br />
since the value of holdings may rise as well as fall. The Fund's market price risk is managed<br />
through close monitoring of market fluctuation and timely disposal of its listed investments.<br />
As for the non-public investment portfolio the Fund held as of the balance sheet date, it is<br />
expected that such investment will be disposed of for cash or publicly traded securities. At the<br />
end of the Fund's life any remaining portfolio company securities may be distributed in specie<br />
notwithstanding the absence of a public market for such securities. Limited Partner may need to<br />
hold such securities for an indefinite period of time and may have difficulty recovering their<br />
capital from such investments. The General Partner mitigates the risk through careful planning of<br />
portfolio companies' exit models and timetables both before investment and after investment.<br />
As at 31 December <strong>2012</strong>, if the fair values of the Fund's investments as determined by the General<br />
Partner of the Fund based on the methodologies described in Notes 3 "Financial instruments" had<br />
increased or decreased by 10%, the partners' capital of the Fund would increase or decrease by<br />
approximately US$ 4,400,331 accordingly.<br />
Credit risk<br />
The Fund takes on exposure to credit risk, which is the risk that counterparty will default on its<br />
contractual obligations resulting in financial loss to the Fund. The credit risk exposed at 31<br />
December as follows:<br />
<strong>2012</strong> 2011<br />
US$ US$<br />
Prepayment and receivables 3,192 245,495<br />
_____ _______<br />
_____ _______<br />
Liquidity risk<br />
All the investments the Fund held are unquoted and subject to specific restriction on<br />
transferability and disposal. Consequently, risks exist that the Fund might not be able to readily<br />
dispose of its holdings in such market or investments when it chooses and also that the price<br />
attained on a disposal is below the amount at which such investments are included in the Fund's<br />
consolidated statement of financial position.<br />
The total liability of the Fund is less than 0.21% of partners' capital.<br />
36 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
- 19 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
5. FINANCIAL INSTRUMENTS - continued<br />
5.2 Fair value of financial instruments<br />
The fair value of financial assets traded in active markets (such as publicly traded derivatives and<br />
trading securities) are based on quoted market prices at the close of trading on the year end date.<br />
The quoted market price used for financial assets held by the Fund is the current bid price; the<br />
appropriate quoted market price for financial liabilities is the current asking price. When the Fund<br />
holds derivatives with offsetting market risks, it uses mid-market prices as a basis for establishing<br />
fair values for the offsetting risk positions and applies this bid or asking price to the net open<br />
position, as appropriate.<br />
A financial instrument is regarded as quoted in an active market if quoted prices are readily and<br />
regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory<br />
agency, and those prices represent actual and regularly occurring market transactions on an arm's<br />
length basis.<br />
The fair value of financial assets that are not traded in an active market is determined by using<br />
valuation techniques. The Fund uses a variety of methods and makes assumptions that are based<br />
on market conditions existing at each year end date. Valuation techniques used for nonstandardised<br />
financial instruments such as options, currency swaps and other over-the-counter<br />
derivatives, include the use of comparable recent arm's length transactions, reference to other<br />
instruments that are substantially the same, discounted cash flow analysis, option pricing models<br />
and other valuation techniques commonly used by market participants making the maximum use<br />
of market inputs and relying as little as possible on entity-specific inputs.<br />
For instruments for which there is no active market, the Fund may use internally developed<br />
models, which are usually based on valuation methods and techniques generally recognised as<br />
standard within the industry. Valuation models are used primarily to value unlisted equity, debt<br />
securities and other debt instruments for which markets were or have been inactive during the<br />
financial year. Some of the inputs to these models may not be market observable and are therefore<br />
estimated based on assumptions.<br />
The output of a model is always an estimate or approximation of a value that cannot be<br />
determined with certainty, and valuation techniques employed may not fully reflect all factors<br />
relevant to the positions the Fund holds. Valuations are therefore adjusted, where appropriate, to<br />
allow for additional factors including model risk, liquidity risk and counterparty risk.<br />
The carrying value less impairment provision of other receivables and payables are assumed to<br />
approximate their fair values.<br />
The following table provides an analysis of financial instruments that are measured subsequent to<br />
initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which the fair<br />
value is observable.<br />
- 20 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 37
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
5. FINANCIAL INSTRUMENTS - continued<br />
5.2 Fair value of financial instruments - continued<br />
38 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
Level 1 fair value measurements are those derived from quoted prices (unadjusted) in<br />
active markets for identical assets or liabilities.<br />
Level 2 fair value measurements are those derived from inputs other than quoted prices<br />
included within Level 1 that are observable for the asset or liability, either directly (i.e. as<br />
prices) or indirectly (i.e. derived from prices).<br />
Level 3 fair value measurements are those derived from valuation techniques that include<br />
inputs for the asset or liability that are not based on observable market data (unobservable<br />
inputs).<br />
31/12/<strong>2012</strong><br />
Level 1 Level 2 Level 3 Total<br />
US$ US$ US$ US$<br />
Financial assets at fair value<br />
through profit or loss - - 44,003,308 44,003,308<br />
______ ______ _________ _________<br />
Total - - 44,003,308 44,003,308<br />
______ ______ _________ _________<br />
______ ______ _________ _________<br />
31/12/2011<br />
Level 1 Level 2 Level 3 Total<br />
US$ US$ US$ US$<br />
Financial assets at fair value<br />
through profit or loss - - 28,166,701 28,166,701<br />
______ ______ _________ _________<br />
Total - - 28,166,701 28,166,701<br />
______ ______ _________ _________<br />
______ ______ _________ _________<br />
Reconciliation of Level 3 fair value measurements of financial assets<br />
Fair value through<br />
Note profit or loss<br />
US$<br />
Closing balance as at 1 January 2011 15,531,616<br />
Total gains or losses:<br />
- in profit or loss (20,317)<br />
Purchase of investment 12,655,402<br />
_________<br />
Closing balance as at 31 December 2011 28,166,701<br />
_________<br />
Total gains or losses:<br />
- in profit or loss (508,784)<br />
Purchase of investment 16,614,897<br />
Cost adjustment 6 (1) (269,506)<br />
_________<br />
Closing balance as at 31 December <strong>2012</strong> 44,003,308<br />
_________<br />
- 21 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
6. FINANCIAL ASSET AT FAIR VALUE THROUGH PROFIT OR LOSS<br />
As at 31 December <strong>2012</strong> As at 31 December 2011<br />
Notes Cost Fair value Equity share Cost Fair value Equity share<br />
US$ US$ % US$ US$ %<br />
Preferred Share Investment<br />
Jiangsu Feida Steel Plate<br />
Joint Stock Co., Ltd. 11,916,977 11,916,977 14.30 11,916,977 11,916,977 14.30<br />
Nanjing Handson Co., Ltd. (1) 3,899,779 3,650,344 6.35 4,169,285 4,169,285 6.35<br />
China Dadi Chemical Limited (2) 5,462,040 6,743,895 3.84 5,462,040 5,462,040 4.44<br />
Ordinary Share Investment<br />
IAT Automobile Technology Co., Ltd 1,984,868 1,527,252 3.44 1,984,868 3,594,322 3.44<br />
Guangzhou Men's Life<br />
Personal Care Co., Ltd. (3) 3,630,385 4,156,251 14.36 3,024,077 3,024,077 12.77<br />
Juxin International Leasing Co., Ltd (4) 7,872,548 7,872,548 4.83 - - -<br />
Shanghai Fudan-Zhangjiang<br />
Bio-Pharmaceutical Co., Ltd. (5) 8,136,041 8,136,041 7.07 - - -<br />
______ ______ ______ ______<br />
Total Financial Asset at Fair<br />
value through Profit or Loss 42,902,638 44,003,308 26,557,247 28,166,701<br />
______ ______ ______ ______<br />
(1) Pursuant to an investment agreement signed on 28 January 2011, CNEI Fund II CJV<br />
invested US$10.88 million to acquire 16.59% share of Nanjing Handson Co., Ltd.<br />
("Handson"), in which US$10.18 million had been paid but US$0.7 million had not yet<br />
paid as at 31 December 2011. Since Handson did not achieve the agreed profit target,<br />
CNEI Fund II CJV will not make the last milestone payment; accordingly the investment<br />
cost of Handson has been adjusted.<br />
(2) Pursuant to a purchase agreement signed on 12 April <strong>2012</strong>, China Dadi Chemical Limited<br />
("Dadi") completed a new round of financing with a new investor, to whom 3,400,000<br />
preference shares were issued; and Dadi acquired Shouguang Wanquan Salt Chemical Co.,<br />
Ltd. for consideration of 1,000,000 Ordinary Shares. As a result, the Fund's share interest<br />
in Dadi was diluted from 4.44% to 3.84%.<br />
(3) Pursuant to an investment agreement signed in December 2011, CNEI Fund II CJV has the<br />
option to invest additional RMB10 million (Equivalent to US$1.58 million) with the same<br />
valuation within 12 months given Guangzhou Men's Life Personal Care Co., Ltd.("Men's<br />
Life) has further financing needs. CNEI Fund II CJV executed the option during the<br />
period of <strong>2012</strong>. As a result, the share percentage held by CNEI Fund II CJV increased<br />
from 33.3% to 37.5%. Based on the proportionate interest that the Fund accounts for<br />
CNEI Fund II CJV, the Fund held 14.36% equity shares of Men's Life.<br />
(4) Pursuant to an investment agreement signed on 10 December <strong>2012</strong>, CNEI Fund II CJV<br />
invested US$20 million to acquire 12.28% share of Juxin International Leasing Co., Ltd<br />
("Juxin"), one of the largest financial leasing companies in China's education sector.<br />
Based on the proportionate interest that the Fund accounts for CNEI Fund II CJV, the<br />
Fund held 4.83% equity shares of Juxin.<br />
(5) Pursuant to a purchase agreement signed on 1 February <strong>2012</strong>, CNEI Fund II CJV acquired<br />
18.45% of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. ("Fudan-Zhangjiang")<br />
from China General Technology (Group) Holding Co., Ltd, for consideration of<br />
RMB133,597,372 (equivalent to US$21,239,947). Fudan-Zhangjiang is one of very few<br />
Chinese pharmaceutical companies dedicated to new drug development. Based on the<br />
proportionate interest that the Fund accounts for CNEI Fund II CJV, the Fund held 7.07%<br />
equity shares of Fudan-Zhangjiang.<br />
- 22 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 39
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
7. PARTNERS' CAPITAL<br />
40 <strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS<br />
Under the Fund Contract, the Limited Partners have agreed to contribute capital, as requested by<br />
the General Partner, up to the amount of their total commitments. The total capital commitments<br />
are reconciled to the contributed capital as follows:<br />
<strong>2012</strong> 2011<br />
US$ US$<br />
As at 31 December<br />
Total capital committed 100,500,000 100,500,000<br />
Less: Outstanding capital commitments not yet called __________ (43,661,624) __________ (63,837,028)<br />
Total capital contribution 56,838,376 36,662,972<br />
__________ __________<br />
__________ __________<br />
Limited Partners has contributed 56.56% of their capital commitment (2011: 36.48%).<br />
8. RELATED PARTY TRANSACTIONS<br />
(1) Significant related party transactions<br />
(a) <strong>Management</strong> fee<br />
The Investment Manager, New Enterprise <strong>Management</strong> Co. Ltd., is entitled to<br />
management fee, as set forth in the Fund Contract. <strong>Management</strong> fee is accrued<br />
monthly and payable semi-annually.<br />
The Investment Manager charged US$2,512,500 in <strong>2012</strong> as management fee at<br />
2.5% per annum on limited partners' capital commitment, excluding the designated<br />
limited partner affiliated with General Partner (2011: US$2,512,500).<br />
(b) Administration fee<br />
TMF Fund Services Asia Limited is the Fund's Administrator. The administration<br />
fee is calculated based on the capital contribution, in accordance with the<br />
Administration Agreement. The Administrator charged US$80,724 in <strong>2012</strong> as<br />
administration fee (2011: US$59,531).<br />
(2) Balance with related parties<br />
As at 31 As at 31<br />
December <strong>2012</strong> December 2011<br />
US$ US$<br />
Due from related parties<br />
- Due from Limited Partner 1,870 1,460<br />
- Prepaid to other related parties 1,322 1,293<br />
______ ______<br />
______ ______<br />
Due to related parties<br />
- Due to the Administrator 22,221 16,040<br />
- Due to China New Enterprise Investment Co. 198 22,722<br />
- Due to other related parties<br />
______<br />
2,251<br />
______ ______<br />
8,215<br />
______<br />
- 23 -
CHINA NEW ENTERPRISE INVESTMENT FUND II (PARALLEL), L.P.<br />
9. CONTINGENCIES<br />
In the normal course of business, the Fund enters into contracts that contain a variety of<br />
representations and warranties and which provide general indemnifications. Based on experience,<br />
the Fund expects the risk of loss related to the Fund's indemnifications to be remote.<br />
10. INVESTMENT COMMITMENT<br />
Pursuant to a purchase agreement signed on 06 February <strong>2012</strong>, CNEI Fund II CJV will acquire<br />
3.65% of Fudan-Zhangjiang from Shanghai Zhangjiang Hi-tech Park Development Co., for<br />
consideration of RMB25,915,096 (equivalent to US$4,122,996). As at 31 December <strong>2012</strong>, the<br />
payment is pending for the approvals by Chinese Authorities therefore CNEI Fund II CJV has a<br />
contingent obligation of RMB25,915,096 (equivalent to US$4,122,996). Based on the<br />
proportionate interest that the Fund accounts for CNEI Fund II CJV, the Fund has a contingent<br />
obligation of RMB9,927,317 (equivalent to US$1,579,340).<br />
11. SUBSEQUENT EVENT<br />
Subsequent events have been evaluated through 29 March <strong>2012</strong>, which is the date that these<br />
consolidated financial statements were available to be issued. As a result of the Fund's evaluation,<br />
the Fund noted no subsequent events that require adjustment to, or disclosure in, these<br />
consolidated financial statements.<br />
- 24 -<br />
<strong>Årsrapport</strong> <strong>PRE</strong> China Private Equity II AS 41
<strong>PRE</strong> <strong>Management</strong><br />
Postboks 1224 Vika<br />
Kronprinsesse Märthas plass 1<br />
0110 Oslo<br />
Design og produksjon: www.kursiv.no